More on ONC
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $292.94 |
|
|||
| Open | $292.50 | ||||
| 52 Wk High | $0.35 | ||||
| 52 Wk Low | $0.35 | ||||
| Day High | $301.49 | ||||
| Day Low | $290.93 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 298,081 | ||||
- BeOne Medicines (ONC) PT Lowered to $412 at Bernstein SocGen Group
- BeOne Medicines (ONC) PT Raised to $430 at Citi
- Bernstein on BeOne Medicines (ONC): 'A Good Opportunity to Buy Now'
- BeOne Medicines (ONC) PT Raised to $412 at Truist Securities
- BeOne Medicines (ONC) PT Raised to $410 at Guggenheim
- BeOne Medicines (ONC) PT Raised to $405 at Barclays
- BeOne Medicines (ONC) PT Raised to $425 at RBC Capital
- BeiGene, Ltd. (ONC) Tops Q4 EPS by 42c, provides guidance
- BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership
- BeOne Medicines to Present at Upcoming Investor Conferences
Entities mentioned with ONC
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- Canaccord Genuity | View Related Stories »
- RBC Capital | View Related Stories »
- Show More...
